Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Winston

Showing results (281-290 of 290) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 290 results.
Cancer Research|August 17, 2010
GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signalingAilin Bai, Kristan Meetze, Nhi Y Vo, et al.
Plos Biology|September 24, 2025
Extinction and subsequent updating of innate fear responses to a visual looming stimulus rely on hippocampus-dependent mechanismsPaul B Conway, Livia Autore, Andrea Muñoz Zamora, et al.
Cancer Treatment and Research Communications|July 17, 2021
Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibodyKenna Shirasuna, Gerald Koelsch, Cynthia Seidel-Dugan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 29, 2026
Splice isoforms of the histone variant macroH2A1 differentially regulate hippocampal gene expression and memory formationTimothy A B McLean, Zhenhong Jin, Luca A Hategan, et al.
Journal of Virology|July 30, 2024
rAAV expressing a COBRA-designed influenza hemagglutinin generates a protective and durable adaptive immune response with a single doseKristin B Wiggins, Stephen M Winston, Isaiah L Reeves, et al.
Molecular Therapy. Methods & Clinical Development|February 25, 2022
Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector prepsMark A Brimble, Pei-Hsin Cheng, Stephen M Winston, et al.
Nucleic Acids Research|July 25, 2014
5' isomiR variation is of functional and evolutionary importanceGeok Chin Tan, Elcie Chan, Attila Molnar, et al.
Molecular Therapy. Advances|May 15, 2026
Rational engineering of the P5 TRS-mimic site and REP78/68 start codon yields promoter variants that improve rAAV purity while maintaining high titersStephen M Winston, Mark A Brimble, Kristin B Wiggins, et al.
Cancer Immunology Research|February 13, 2026
WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" MuteinsChristopher J Nirschl, Kulandayan K Subramanian, Heather R Brodkin, et al.
Epilepsy & Behavior : E&B|February 28, 2026
Neuropsychological assessments in a large cohort of pediatric palliative epilepsy surgery patientsM Jeno, J Koop, M Gabriel, et al.
Pageof 29

Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
Cancer Research|August 17, 2010
GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signalingAilin Bai, Kristan Meetze, Nhi Y Vo, et al.
Plos Biology|September 24, 2025
Extinction and subsequent updating of innate fear responses to a visual looming stimulus rely on hippocampus-dependent mechanismsPaul B Conway, Livia Autore, Andrea Muñoz Zamora, et al.
Cancer Treatment and Research Communications|July 17, 2021
Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibodyKenna Shirasuna, Gerald Koelsch, Cynthia Seidel-Dugan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 29, 2026
Splice isoforms of the histone variant macroH2A1 differentially regulate hippocampal gene expression and memory formationTimothy A B McLean, Zhenhong Jin, Luca A Hategan, et al.
Journal of Virology|July 30, 2024
rAAV expressing a COBRA-designed influenza hemagglutinin generates a protective and durable adaptive immune response with a single doseKristin B Wiggins, Stephen M Winston, Isaiah L Reeves, et al.
Molecular Therapy. Methods & Clinical Development|February 25, 2022
Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector prepsMark A Brimble, Pei-Hsin Cheng, Stephen M Winston, et al.
Nucleic Acids Research|July 25, 2014
5' isomiR variation is of functional and evolutionary importanceGeok Chin Tan, Elcie Chan, Attila Molnar, et al.
Molecular Therapy. Advances|May 15, 2026
Rational engineering of the P5 TRS-mimic site and REP78/68 start codon yields promoter variants that improve rAAV purity while maintaining high titersStephen M Winston, Mark A Brimble, Kristin B Wiggins, et al.
Cancer Immunology Research|February 13, 2026
WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" MuteinsChristopher J Nirschl, Kulandayan K Subramanian, Heather R Brodkin, et al.
Epilepsy & Behavior : E&B|February 28, 2026
Neuropsychological assessments in a large cohort of pediatric palliative epilepsy surgery patientsM Jeno, J Koop, M Gabriel, et al.
Pageof 29